Figure 2

3a-G1 treated PBMCs show progressive enrichment in NK cells at CD4⁺ T cell expense during the second week of culture. a) CD25 expression gated on CD4⁺ T cells (left graphs) and NK cell versus CD4⁺ T cell proportion at days 5, 7, 9 and 12 of culture (right graph). b) Amplification factor (left) and proportion (right) of NK and CD4⁺ T cell populations among PBMCs from eleven different donors after 12 to 14 days treatment with 3a-G1. Histograms indicate the means of the data collected from the eleven donors (Wilcoxon signed rank t test, *: P ≤ 0.05, **: P ≤ 0.01, ***: P ≤ 0.001).